
Dr. Stephen Steinberg, who previously served as president and CEO, remains on the Portland, Oregon–based company’s leadership team as chief medical officer.
Aldrich most recently served as an independent consultant focusing on medical device strategy, commercialization and operations. According to LinkedIn, he also served as VP of commercial & strategy at Motus GI from January 2023 to July 2023, having been VP of global marketing & strategy from September 2019 until the start of 2023.
In a news release, EndoSound said Aldrich brings operational and commercial leadership abilities paired with experience in both interventional gastroenterology and medical device imaging. His experience also spans startups and small/mid-cap companies, both privately and publicly held.
Aldrich’s appointment comes just weeks after EndoSound received FDA 510(k) clearance for its EndoSound Vision System (EVS). The EVS endoscopic ultrasound (EUS) device is attached to upper gastrointestinal endoscopes. According ot the company, it easily integrates to any endoscopy center’s existing ecosystem and provides access to both imaging and a therapeutic procedure.
“I am honored and humbled to be able to assume the role of CEO,” Aldrich said. “Stephen has done a remarkable job in getting EndoSound so far in its journey. EndoSound EVS is a customer-focused product that can reduce aggregate healthcare costs and improve patient experience and lives. It is exciting to be bringing this technology that so clearly can transform the GI market and patient access to endoscopic ultrasound to market.
“I look forward to working closely with the EndoSound board of directors, Stephen, and the rest of the EndoSound team in successfully launching EVS and making the company’s immense potential a reality.”